Citations (133)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (11)
Ningfei Ji, Mingshun Zhang, Liang Ren, Yunyun Wang, Bicheng Hu, Jie Xiang, Yingyun Gong, Chaojie Wu, Guoqiang Qu, Wenqiu Ding, Zhiqiang Yin, Shan Li, Zhengxia Wang, Lianzheng Zhou, Xueqin Chen, Yuan Ma, Jinhai Tang, Yun Liu, Liang Liu & Mao Huang. (2022) SARS-CoV-2 in the pancreas and the impaired islet function in COVID-19 patients. Emerging Microbes & Infections 11:1, pages 1115-1125.
Read now
Read now
Amresh Kumar, Amit Ladha, Ankita Choudhury, Abu Md Ashif Ikbal, Bedanta Bhattacharjee, Tanmay Das, Gaurav Gupta, Chhavi Sharma, Adity Sarbajna, Subhash C Mandal, Manabendra Dutta Choudhury, Nahid Ali, Petr Slama, Nima Rezaei, Partha Palit & Onkar Nath Tiwari. (2022) The chimera of S1 and N proteins of SARS-CoV-2: can it be a potential vaccine candidate for COVID-19?. Expert Review of Vaccines 21:8, pages 1071-1086.
Read now
Read now
Marta (M) Valera-Rubio, María Isabel (MI) Sierra-Torres, Raquel (R) Castillejo García, Jaime (J) Cordero-Ramos, María Reyes (MR) López-Márquez, Óscar (O) Cruz-Salgado & Miguel Ángel (MA) Calleja-Hernández. (2022) Adverse events reported after administration of BNT162b2 and mRNA-1273 COVID-19 vaccines among hospital workers: a cross-sectional survey-based study in a Spanish hospital. Expert Review of Vaccines 21:4, pages 533-540.
Read now
Read now
Parisa Lotfinejad, Zahra Asadzadeh, Shiva Najjary, Mohammad Hossein Somi, Khalil Hajiasgharzadeh, Ahad Mokhtarzadeh, Afshin Derakhshani, Elmira Roshani & Behzad Baradaran. (2022) COVID-19 Infection: Concise Review Based on the Immunological Perspective. Immunological Investigations 51:2, pages 246-265.
Read now
Read now
Christy J.W. Ledford, Lauren A. Cafferty, Justin X. Moore, Courtney Roberts, Ebony B. Whisenant, Alejandra Garcia Rychtarikova & Dean A. Seehusen. (2022) The dynamics of trust and communication in COVID-19 vaccine decision making: A qualitative inquiry. Journal of Health Communication 27:1, pages 17-26.
Read now
Read now
Vipin M. Vashishtha & Puneet Kumar. (2021) Development of SARS-CoV-2 vaccines: challenges, risks, and the way forward. Human Vaccines & Immunotherapeutics 17:6, pages 1635-1649.
Read now
Read now
Muhammad Bilal & Hafiz M. N. Iqbal. (2020) Recent advances in therapeutic modalities and vaccines to counter COVID-19/SARS-CoV-2. Human Vaccines & Immunotherapeutics 16:12, pages 3034-3042.
Read now
Read now
Mohd. Iqbal Yatoo, Zeenat Hamid, Oveas Rafiq Parray, Aasim Habib Wani, Abrar Ul Haq, Archana Saxena, Shailesh Kumar Patel, Mamta Pathak, Ruchi Tiwari, Yashpal Singh Malik, Ranjit Sah, Ali A. Rabaan, Alfonso J. Rodriguez Morales & Kuldeep Dhama. (2020) COVID-19 - Recent advancements in identifying novel vaccine candidates and current status of upcoming SARS-CoV-2 vaccines. Human Vaccines & Immunotherapeutics 16:12, pages 2891-2904.
Read now
Read now
Jianhui Nie, Qianqian Li, Jiajing Wu, Chenyan Zhao, Huan Hao, Huan Liu, Li Zhang, Lingling Nie, Haiyang Qin, Meng Wang, Qiong Lu, Xiaoyu Li, Qiyu Sun, Junkai Liu, Changfa Fan, Weijin Huang, Miao Xu & Youchun Wang. (2020) Establishment and validation of a pseudovirus neutralization assay for SARS-CoV-2. Emerging Microbes & Infections 9:1, pages 680-686.
Read now
Read now
Derrick Louz, Hans E. Bergmans, Birgit P. Loos & Rob C. Hoeben. (2013) Animal models in virus research: their utility and limitations. Critical Reviews in Microbiology 39:4, pages 325-361.
Read now
Read now
Shibo Jiang, Maria Elena Bottazzi, Lanying Du, Sara Lustigman, Chien-Te Kent Tseng, Elena Curti, Kathryn Jones, Bin Zhan & Peter J Hotez. (2012) Roadmap to developing a recombinant coronavirus S protein receptor-binding domain vaccine for severe acute respiratory syndrome. Expert Review of Vaccines 11:12, pages 1405-1413.
Read now
Read now
Articles from other publishers (122)
Keda Chen, Ling Zhang, Zhongbiao Fang, Jiaxuan Li, Chaonan Li, Wancheng Song, Zhiwei Huang, Ruyi Chen, Yanjun Zhang & Jianhua Li. (2023) Analysis of the protective efficacy of approved COVID-19 vaccines against Omicron variants and the prospects for universal vaccines. Frontiers in Immunology 14.
Crossref
Crossref
Venkatesan Saravanan, Bharath Kumar Chagaleti, Pavithra Lakshmi Narayanan, Vijay Babu Anandan, Haritha Manoharan, G.V. Anjana, Ramalingam Peraman, S. Karthik Raja Namasivayam, M. Kavisri, Jesu Arockiaraj, Kathiravan Muthu Kumaradoss & Meivelu Moovendhan. (2023)
Discovery and development of
COVID
‐19 vaccine from laboratory to clinic
. Chemical Biology & Drug Design.
Crossref
Crossref
Kriti Negi, Meetu Agarwal, Isha Pahuja, Bhavya Bhardwaj, Mansi Rawat, Ashima Bhaskar & Ved Prakash Dwivedi. (2023) Combating the challenges of COVID-19 pandemic: Insights into molecular mechanisms, immune responses and therapeutics against SARS-CoV-2. Oxford Open Immunology 4:1.
Crossref
Crossref
Susan M. Poutanen. 2023. Principles and Practice of Pediatric Infectious Diseases. Principles and Practice of Pediatric Infectious Diseases
1167
1175.e6
.
Carolina Graña, Lina Ghosn, Theodoros Evrenoglou, Alexander Jarde, Silvia Minozzi, Hanna Bergman, Brian S Buckley, Katrin Probyn, Gemma Villanueva, Nicholas Henschke, Hillary Bonnet, Rouba Assi, Sonia Menon, Melanie Marti, Declan Devane, Patrick Mallon, Jean-Daniel Lelievre, Lisa M Askie, Tamara Kredo, Gabriel Ferrand, Mauricia Davidson, Carolina Riveros, David Tovey, Joerg J Meerpohl, Giacomo Grasselli, Gabriel Rada, Asbjørn Hróbjartsson, Philippe Ravaud, Anna Chaimani & Isabelle Boutron. (2022) Efficacy and safety of COVID-19 vaccines. Cochrane Database of Systematic Reviews 2023:3.
Crossref
Crossref
Murat Kaytaz, Emre Akkaya, Sefika Nur Gumus, Sema Genc, Halim Issever & Beyhan Omer. (2022) IgG-RBD Response Due to Inactivated SARS-CoV-2 Vaccine: Alteration in D-Dimer and Fibrinogen Concentrations, Association with Comorbidities and Adverse Effects. Laboratory Medicine 53:6, pages 590-595.
Crossref
Crossref
Ibrahim A. Shehu, Muhammad K. Musa, Aparna Datta & Amita Verma. (2022) Application of Nanotechnology in COVID-19 Infection: Findings and Limitations. Journal of Nanotheranostics 3:4, pages 203-232.
Crossref
Crossref
Gelareh Abdolmaleki, Mina Azam Taheri, Sarina Paridehpour, Neshaut Mashreghi Mohammadi, Yasaman Ahmadi Tabatabaei, Taraneh Mousavi & Mohsen Amin. (2022) A comparison between SARS-CoV-1 and SARS-CoV2: an update on current COVID-19 vaccines. DARU Journal of Pharmaceutical Sciences 30:2, pages 379-406.
Crossref
Crossref
Isabel Acosta-Coley, Leonor Cervantes-Ceballos, Lesly Tejeda-Benítez, Lucellys Sierra-Márquez, María Cabarcas-Montalvo, María García-Espiñeira, Wilfrido Coronell-Rodríguez & Bárbara Arroyo-Salgado. (2022) Vaccines platforms and COVID-19: what you need to know. Tropical Diseases, Travel Medicine and Vaccines 8:1.
Crossref
Crossref
Ashwani Sharma, Tarun Virmani, Vipluv Pathak, Anjali Sharma, Kamla Pathak, Girish Kumar & Devender Pathak. (2022) Artificial Intelligence-Based Data-Driven Strategy to Accelerate Research, Development, and Clinical Trials of COVID Vaccine. BioMed Research International 2022, pages 1-16.
Crossref
Crossref
Alberto Boretti. (2020) Covid19 pandemic as a further driver of water scarcity in Africa. GeoJournal 87:2, pages 787-814.
Crossref
Crossref
Leonardo Souto Ferreira, Otavio Canton, Rafael Lopes Paixão da Silva, Silas Poloni, Vítor Sudbrack, Marcelo Eduardo Borges, Caroline Franco, Flavia Maria Darcie Marquitti, José Cássio de Moraes, Maria Amélia de Sousa Mascena Veras, Roberto André Kraenkel & Renato Mendes Coutinho. (2022) Assessing the best time interval between doses in a two-dose vaccination regimen to reduce the number of deaths in an ongoing epidemic of SARS-CoV-2. PLOS Computational Biology 18:3, pages e1009978.
Crossref
Crossref
Ramy Mohamed Ghazy, Rasha Ashmawy, Noha Alaa Hamdy, Yasir Ahmed Mohammed Elhadi, Omar Ahmed Reyad, Dina Elmalawany, Abdallah Almaghraby, Ramy Shaaban & Sarah Hamed N. Taha. (2022) Efficacy and Effectiveness of SARS-CoV-2 Vaccines: A Systematic Review and Meta-Analysis. Vaccines 10:3, pages 350.
Crossref
Crossref
M. Gordon Joyce, Hannah A. D. King, Ines Elakhal-Naouar, Aslaa Ahmed, Kristina K. Peachman, Camila Macedo Cincotta, Caroline Subra, Rita E. Chen, Paul V. ThomasWei-Hung ChenRajeshwer S. SankhalaAgnes HajduczkiElizabeth J. Martinez, Caroline E. Peterson, William C. Chang, Misook Choe, Clayton SmithParker J. Lee, Jarrett A. Headley, Mekdi G. TaddeseHanne A. ElyardAnthony CookAlexander Anderson, Kathryn McGuckin Wuertz, Ming DongIsabella Swafford, James Brett Case, Jeffrey R. Currier, Kerri G. LalSebastian Molnar, Manoj S. Nair, Vincent Dussupt, Sharon P. DayeXiankun Zeng, Erica K. Barkei, Hilary M. StaplesKendra Alfson, Ricardo Carrion, Shelly J. Krebs, Dominic Paquin-Proulx, Nicos Karasavva, Victoria R. PolonisLinda L. Jagodzinski, Mihret F. Amare, Sandhya Vasan, Paul T. Scott, Yaoxing Huang, David D. Ho, Natalia de Val, Michael S. Diamond, Mark G. Lewis, Mangala Rao, Gary R. Matyas, Gregory D. Gromowski, Sheila A. PeelNelson L. Michael, Diane L. Bolton & Kayvon Modjarrad. (2022) A SARS-CoV-2 ferritin nanoparticle vaccine elicits protective immune responses in nonhuman primates. Science Translational Medicine 14:632.
Crossref
Crossref
Syed Nisar Hussain Bukhari, Amit Jain, Ehtishamul Haq, Abolfazl Mehbodniya & Julian Webber. (2022) Machine Learning Techniques for the Prediction of B-Cell and T-Cell Epitopes as Potential Vaccine Targets with a Specific Focus on SARS-CoV-2 Pathogen: A Review. Pathogens 11:2, pages 146.
Crossref
Crossref
Shalini Iyer, Rajesh Yadav, Smriti Agarwal, Shashank Tripathi & Rachit Agarwal. (2022) Bioengineering Strategies for Developing Vaccines against Respiratory Viral Diseases. Clinical Microbiology Reviews 35:1.
Crossref
Crossref
Divya Kapoor, Rahul Suryawanshi, Chandrashekhar D. Patil & Deepak Shukla. 2022. Nanotechnological Applications in Virology. Nanotechnological Applications in Virology
279
303
.
Andrés Noé & Katie Ewer. 2022. Vaccinology and Methods in Vaccine Research. Vaccinology and Methods in Vaccine Research
201
222
.
Anthony R. Rees. 2022. A New History of Vaccines for Infectious Diseases. A New History of Vaccines for Infectious Diseases
395
450
.
Rebecca T Veenhuis & Caroline J Zeiss. (2021) Animal Models of COVID-19 II. Comparative Immunology. ILAR Journal 62:1-2, pages 17-34.
Crossref
Crossref
Antonio Muruato, Michelle N. Vu, Bryan A. Johnson, Meredith E. Davis-Gardner, Abigail Vanderheiden, Kumari Lokugamage, Craig Schindewolf, Patricia A. Crocquet-Valdes, Rose M. Langsjoen, Jessica A. Plante, Kenneth S. Plante, Scott C. Weaver, Kari Debbink, Andrew L. Routh, David Walker, Mehul S. Suthar, Pei-Yong Shi, Xuping Xie & Vineet D. Menachery. (2021) Mouse-adapted SARS-CoV-2 protects animals from lethal SARS-CoV challenge. PLOS Biology 19:11, pages e3001284.
Crossref
Crossref
Kiana Shahzamani, Fatemeh Mahmoudian, Shahrzad Ahangarzadeh, Mohammad Mehdi Ranjbar, Leila Beikmohammadi, Samira Bahrami, Elmira Mohammadi, Sahar Esfandyari, Abbas Alibakhshi & Shaghayegh Haghjooy Javanmard. (2021) Vaccine design and delivery approaches for COVID-19. International Immunopharmacology 100, pages 108086.
Crossref
Crossref
Mohamad S. Hakim. (2021) SARS‐CoV‐2, Covid‐19, and the debunking of conspiracy theories. Reviews in Medical Virology 31:6.
Crossref
Crossref
Syed Nisar Hussain Bukhari, Amit Jain, Ehtishamul Haq, Abolfazl Mehbodniya & Julian Webber. (2021) Ensemble Machine Learning Model to Predict SARS-CoV-2 T-Cell Epitopes as Potential Vaccine Targets. Diagnostics 11:11, pages 1990.
Crossref
Crossref
Hadeel T. Al-Jighefee, Hoda Najjar, Muna Nizar Ahmed, Abeer Qush, Sara Awwad & Layla Kamareddine. (2021) COVID-19 Vaccine Platforms: Challenges and Safety Contemplations. Vaccines 9:10, pages 1196.
Crossref
Crossref
Emre Sedar Saygılı & Ersen Karakilic. (2021) Subacute thyroiditis after inactive SARS-CoV-2 vaccine. BMJ Case Reports 14:10, pages e244711.
Crossref
Crossref
Rahim A. Jiwani, Yuxuan Mao, Adrian Pona, Evan Bradner, Jaffer Hussain, J. Stephen Stalls, Paul Cook, Ashley BurchFelix Afriyie, Jonathan Labbe, Ahmed Younes, Mai Badr, Elisabeth Lee & Rachel L. Roper. (2021) Discontinuation of Transmission Precautions for COVID-19 Patients. Infectious Diseases in Clinical Practice 29:5, pages e287-e293.
Crossref
Crossref
Rim Jbeli & Awatef Jelassi. (2021) Current vaccine technology with an emphasis on recombinant measles virus as a new perspective for vaccination against SARS-CoV-2. Euro-Mediterranean Journal for Environmental Integration 6:2.
Crossref
Crossref
Engin Berber, Deepak Sumbria & Nurettin Çanakoğlu. (2021) Meta-analysis and comprehensive study of coronavirus outbreaks: SARS, MERS and COVID-19. Journal of Infection and Public Health 14:8, pages 1051-1064.
Crossref
Crossref
Maryam Bayat, Yahya Asemani & Sajad Najafi. (2021) Essential considerations during vaccine design against COVID-19 and review of pioneering vaccine candidate platforms. International Immunopharmacology 97, pages 107679.
Crossref
Crossref
Dewald Schoeman & Burtram C. Fielding. (2021) Human Coronaviruses: Counteracting the Damage by Storm. Viruses 13:8, pages 1457.
Crossref
Crossref
Jinglu Lyu, Lirong Bao, Xin Shen, Caixia Yan, Cheng Zhang, Wei Wei, Yutao Yang, Jia Li, Jiajia Dong, Liying Xiao, Xuedong Zhou & Yan Li. (2021) The preparation of N-IgY targeting SARS-CoV-2 and its immunomodulation to IFN-γ production in vitro. International Immunopharmacology 96, pages 107797.
Crossref
Crossref
Ahmed Majdi K. Tolah, Sayed S. Sohrab, Khaled Majdi K. Tolah, Ahmed M. Hassan, Sherif A. El-Kafrawy & Esam I. Azhar. (2021) Evaluation of a Pseudovirus Neutralization Assay for SARS-CoV-2 and Correlation with Live Virus-Based Micro Neutralization Assay. Diagnostics 11:6, pages 994.
Crossref
Crossref
Ian McDonald, Sam M. Murray, Catherine J. Reynolds, Daniel M. Altmann & Rosemary J. Boyton. (2021) Comparative systematic review and meta-analysis of reactogenicity, immunogenicity and efficacy of vaccines against SARS-CoV-2. npj Vaccines 6:1.
Crossref
Crossref
Jubeda Begum, Nasir Akbar Mir, Kapil Dev, Bidyarani Buyamayum, Mohd Yaqoob Wani & Meesam Raza. (2020) Challenges and prospects of COVID‐19 vaccine development based on the progress made in SARS and MERS vaccine development. Transboundary and Emerging Diseases 68:3, pages 1111-1124.
Crossref
Crossref
Krista L. Lentine, Roslyn B. Mannon & Michelle A. Josephson. (2021) Practicing With Uncertainty: Kidney Transplantation During the COVID-19 Pandemic. American Journal of Kidney Diseases 77:5, pages 777-785.
Crossref
Crossref
Masarra M. Sakr, Noha S. Elsayed & Ghadir S. El-Housseiny. (2021) Latest updates on SARS-CoV-2 genomic characterization, drug, and vaccine development; a comprehensive bioinformatics review. Microbial Pathogenesis 154, pages 104809.
Crossref
Crossref
Fatima Amanat, Shirin Strohmeier, Raveen Rathnasinghe, Michael Schotsaert, Lynda Coughlan, Adolfo García-Sastre & Florian Krammer. (2021) Introduction of Two Prolines and Removal of the Polybasic Cleavage Site Lead to Higher Efficacy of a Recombinant Spike-Based SARS-CoV-2 Vaccine in the Mouse Model. mBio 12:2.
Crossref
Crossref
Tiziana Ciarambino, Elena Barbagelata, Graziamaria Corbi, Immacolata Ambrosino, Cecilia Politi, Franco Lavalle, Anna Ruggieri & Annamaria Moretti. (2021) Gender differences in vaccine therapy: where are we in COVID-19 pandemic?. Monaldi Archives for Chest Disease.
Crossref
Crossref
Federico Perosa, Elvira Favoino & Marcella Prete. (2021) Why Do We Still Lack a COVID-19 Vaccine? Searching for the Missing Pieces. Endocrine, Metabolic & Immune Disorders - Drug Targets 21:4, pages 567-568.
Crossref
Crossref
Shima Tavakol, Mo S. Alavijeh & Alexander M. Seifalian. (2021) COVID-19 Vaccines in Clinical Trials and their Mode of Action for Immunity against the Virus. Current Pharmaceutical Design 27:13, pages 1553-1563.
Crossref
Crossref
Balasubramanian Ganesh, Thangarasu Rajakumar, Mathiyazhakan Malathi, Natesan Manikandan, Jaganathasamy Nagaraj, Aridoss Santhakumar, Arumugam Elangovan & Yashpal Singh Malik. (2021) Epidemiology and pathobiology of SARS-CoV-2 (COVID-19) in comparison with SARS, MERS: An updated overview of current knowledge and future perspectives. Clinical Epidemiology and Global Health 10, pages 100694.
Crossref
Crossref
Arezoo Beig Parikhani, Masoume Bazaz, Hadi Bamehr, Sepideh Fereshteh, Shahin Amiri, Mostafa Salehi-Vaziri, Arash Arashkia & Kayhan Azadmanesh. (2021) The Inclusive Review on SARS-CoV-2 Biology, Epidemiology, Diagnosis, and Potential Management Options. Current Microbiology 78:4, pages 1099-1114.
Crossref
Crossref
Qingmei Jia, Helle Bielefeldt-Ohmann, Rachel M. Maison, Saša Masleša-Galić, Sarah K. Cooper, Richard A. Bowen & Marcus A. Horwitz. (2021) Replicating bacterium-vectored vaccine expressing SARS-CoV-2 Membrane and Nucleocapsid proteins protects against severe COVID-19-like disease in hamsters. npj Vaccines 6:1.
Crossref
Crossref
Raquel L. RussellPeter PelkaBrian L. Mark. (2021) Frontrunners in the race to develop a SARS-CoV-2 vaccine. Canadian Journal of Microbiology 67:3, pages 189-212.
Crossref
Crossref
Ramandeep Singh, Alisha Kang, Xiangqian Luo, Mangalakumari Jeyanathan, Amy Gillgrass, Sam Afkhami & Zhou Xing. (2021) COVID‐19: Current knowledge in clinical features, immunological responses, and vaccine development. The FASEB Journal 35:3.
Crossref
Crossref
Soheila Molaei, Masoomeh Dadkhah, Vahid Asghariazar, Chiman Karami & Elham Safarzadeh. (2021) The immune response and immune evasion characteristics in SARS-CoV, MERS-CoV, and SARS-CoV-2: Vaccine design strategies. International Immunopharmacology 92, pages 107051.
Crossref
Crossref
Bhavesh D. Kevadiya, Jatin Machhi, Jonathan Herskovitz, Maxim D. Oleynikov, Wilson R. Blomberg, Neha Bajwa, Dhruvkumar Soni, Srijanee Das, Mahmudul Hasan, Milankumar Patel, Ahmed M. Senan, Santhi Gorantla, JoEllyn McMillan, Benson Edagwa, Robert Eisenberg, Channabasavaiah B. Gurumurthy, St Patrick M. Reid, Chamindie Punyadeera, Linda Chang & Howard E. Gendelman. (2021) Pharmacotherapeutics of SARS-CoV-2 Infections. Journal of Neuroimmune Pharmacology 16:1, pages 12-37.
Crossref
Crossref
Vahid Alimardani, Samira Sadat Abolmaali & Ali Mohammad Tamaddon. (2021) Recent Advances on Nanotechnology-Based Strategies for Prevention, Diagnosis, and Treatment of Coronavirus Infections. Journal of Nanomaterials 2021, pages 1-20.
Crossref
Crossref
Kimia Kardani & Azam Bolhassani. (2021) Vaccine Development Against SARS-CoV-2: From Virology to Vaccine Clinical Trials. Coronaviruses 2:2, pages 159-171.
Crossref
Crossref
Marcelle Moura Silveira, Gustavo Marçal Schmidt Garcia Moreira & Marcelo Mendonça. (2021) DNA vaccines against COVID-19: Perspectives and challenges. Life Sciences 267, pages 118919.
Crossref
Crossref
Cole J. Batty, Mark T. Heise, Eric M. Bachelder & Kristy M. Ainslie. (2021) Vaccine formulations in clinical development for the prevention of severe acute respiratory syndrome coronavirus 2 infection. Advanced Drug Delivery Reviews 169, pages 168-189.
Crossref
Crossref
Sanjay Kumar Mishra & Timir Tripathi. (2021) One year update on the COVID-19 pandemic: Where are we now?. Acta Tropica 214, pages 105778.
Crossref
Crossref
Jyoti Verma & Naidu Subbarao. (2021) A comparative study of human betacoronavirus spike proteins: structure, function and therapeutics. Archives of Virology.
Crossref
Crossref
Muhammad Yameen, Sara Sattar, Ayesha Khalid, Muhammad Aamir Aslam, Nishat Zafar, Muhammad Hassan Saeed, Muhammad Haseeb Arif, Muhammad Jahangeer, Azka Qadeer, Shoukat Hussain, Muhammad Aamir, Sania Mukhtar, Huma Nasir & Asif Shahzad. (2021) Novel Sars-Cov-2 Pandemic Transmission With Ongoing Antiviral Therapies And Vaccine Design. Postępy Mikrobiologii - Advancements of Microbiology 60:1, pages 13-20.
Crossref
Crossref
Tiziana Ciarambino, Ombretta Para & Mauro Giordano. (2021) Immune system and COVID-19 by sex differences and age. Women's Health 17, pages 174550652110222.
Crossref
Crossref
Devasena T.Devasena T.. 2021. Nanotechnology-COVID-19 Interface. Nanotechnology-COVID-19 Interface
115
126
.
Fataneh Fatemi, Zahra Hassani Nejad & Seyed Ehsan Ranaei Siadat. 2021. COVID-19. COVID-19
149
185
.
Hina Qaiser, Roheena Abdullah, Tehreema Iftikhar, Hammad Majeed & Imran Imran. 2021. Alternative Medicine Interventions for COVID-19. Alternative Medicine Interventions for COVID-19
205
235
.
Mohammad Behdad Jamshidi, Ali Lalbakhsh, Jakub Talla, Zdeněk Peroutka, Sobhan Roshani, Vaclav Matousek, Saeed Roshani, Mirhamed Mirmozafari, Zahra Malek, Luigi La Spada, Asal Sabet, Mojgan Dehghani, Morteza Jamshidi, Mohammad Mahdi Honari, Farimah Hadjilooei, Alireza Jamshidi, Pedram Lalbakhsh, Hamed Hashemi-Dezaki, Sahar Ahmadi & Saeedeh Lotfi. 2021. Emerging Technologies During the Era of COVID-19 Pandemic. Emerging Technologies During the Era of COVID-19 Pandemic
9
31
.
Muhammad Tahir ul Qamar, Farah Shahid, Sadia Aslam, Usman Ali Ashfaq, Sidra Aslam, Israr Fatima, Muhammad Mazhar Fareed, Ali Zohaib & Ling-Ling Chen. (2020) Reverse vaccinology assisted designing of multiepitope-based subunit vaccine against SARS-CoV-2. Infectious Diseases of Poverty 9:1.
Crossref
Crossref
Ali A. Rabaan, Shamsah H. Al-Ahmed, Ranjit Sah, Ruchi Tiwari, Mohd. Iqbal Yatoo, Shailesh Kumar Patel, Mamta Pathak, Yashpal Singh Malik, Kuldeep Dhama, Karam Pal Singh, D. Katterine Bonilla-Aldana, Shafiul Haque, Dayron F. Martinez-Pulgarin, Alfonso J. Rodriguez-Morales & Hakan Leblebicioglu. (2020) SARS-CoV-2/COVID-19 and advances in developing potential therapeutics and vaccines to counter this emerging pandemic. Annals of Clinical Microbiology and Antimicrobials 19:1.
Crossref
Crossref
Panpan Lin, Manni Wang, Yuquan Wei, Taewan Kim & Xiawei Wei. (2020) Coronavirus in human diseases: Mechanisms and advances in clinical treatment. MedComm 1:3, pages 270-301.
Crossref
Crossref
Rupinder Mann, Abhilash Perisetti, Mahesh Gajendran, Zainab Gandhi, Chandraprakash Umapathy & Hemant Goyal. (2020) Clinical Characteristics, Diagnosis, and Treatment of Major Coronavirus Outbreaks. Frontiers in Medicine 7.
Crossref
Crossref
Mohammad S. Khuroo, Mohammad Khuroo, Mehnaaz S. Khuroo, Ahmad A. Sofi & Naira S. Khuroo. (2020) COVID-19 Vaccines: A Race Against Time in the Middle of Death and Devastation!. Journal of Clinical and Experimental Hepatology 10:6, pages 610-621.
Crossref
Crossref
Rasoul Mirzaei, Rokhsareh Mohammadzadeh, Farzad Mahdavi, Fariba Badrzadeh, Sheida Kazemi, Mehdi Ebrahimi, Fatemeh Soltani, Sima Kazemi, Ali Salimi Jeda, Mohammad Darvishmotevalli, Rasoul Yousefimashouf, Hossein Keyvani & Sajad Karampoor. (2020) Overview of the current promising approaches for the development of an effective severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine. International Immunopharmacology 88, pages 106928.
Crossref
Crossref
Bahaa Abu-Raya, Giovanni Battista Migliori, Miguel O'Ryan, Kathryn Edwards, Antoni Torres, Jan-Willem Alffenaar, Anne-Grete Märtson, Rosella Centis, Lia D'Ambrosio, Katie Flanagan, Ivan Hung, Fulvio Lauretani, Chi Chi Leung, Elke Leuridan, Kirsten Maertens, Marcello Giuseppe Maggio, Simon Nadel, Niel Hens, Hubert Niesters, Albert Osterhaus, Emanuele Pontali, Nicola Principi, Denise Rossato Silva, Saad Omer, Antonio Spanevello, Nicola Sverzellati, Tina Tan, Juan Pablo Torres-Torreti, Dina Visca & Susanna Esposito. (2020) Coronavirus Disease-19: An Interim Evidence Synthesis of the World Association for Infectious Diseases and Immunological Disorders (Waidid). Frontiers in Medicine 7.
Crossref
Crossref
Yetian Dong, Tong Dai, Yujun Wei, Long Zhang, Min Zheng & Fangfang Zhou. (2020) A systematic review of SARS-CoV-2 vaccine candidates. Signal Transduction and Targeted Therapy 5:1.
Crossref
Crossref
Yi Liu, Kai Wang, Tarik F. Massoud & Ramasamy Paulmurugan. (2020) SARS-CoV-2 Vaccine Development: An Overview and Perspectives. ACS Pharmacology & Translational Science 3:5, pages 844-858.
Crossref
Crossref
Katie L. Flanagan, Emma Best, Nigel W. Crawford, Michelle Giles, Archana Koirala, Kristine Macartney, Fiona Russell, Benjamin W. Teh & Sophie CH Wen. (2020) Progress and Pitfalls in the Quest for Effective SARS-CoV-2 (COVID-19) Vaccines. Frontiers in Immunology 11.
Crossref
Crossref
Yetian Dong, Tong Dai, Jun Liu, Long Zhang & Fangfang Zhou. (2020) Coronavirus in Continuous Flux: From SARS‐CoV to SARS‐CoV‐2. Advanced Science 7:20.
Crossref
Crossref
Bethany Dearlove, Eric Lewitus, Hongjun Bai, Yifan Li, Daniel B. Reeves, M. Gordon Joyce, Paul T. ScottMihret F. Amare, Sandhya Vasan, Nelson L. Michael, Kayvon Modjarrad & Morgane Rolland. (2020) A SARS-CoV-2 vaccine candidate would likely match all currently circulating variants. Proceedings of the National Academy of Sciences 117:38, pages 23652-23662.
Crossref
Crossref
Ayman A. Swelum, Manal E. Shafi, Najah M. Albaqami, Mohamed T. El-Saadony, Ahmed Elsify, Mohamed Abdo, Ayman E. Taha, Abdel-Moneim E. Abdel-Moneim, Naif A. Al-Gabri, Amer A. Almaiman, Abdullah Saleh Al-wajeeh, Vincenzo Tufarelli, Vito N. Staffa & Mohamed E. Abd El-Hack. (2020) COVID-19 in Human, Animal, and Environment: A Review. Frontiers in Veterinary Science 7.
Crossref
Crossref
Maria Trovato, Rossella Sartorius, Luciana D’Apice, Roberta Manco & Piergiuseppe De Berardinis. (2020) Viral Emerging Diseases: Challenges in Developing Vaccination Strategies. Frontiers in Immunology 11.
Crossref
Crossref
Archana Koirala, Ye Jin Joo, Ameneh Khatami, Clayton Chiu & Philip N. Britton. (2020) Vaccines for COVID-19: The current state of play. Paediatric Respiratory Reviews 35, pages 43-49.
Crossref
Crossref
Satish Chandra Pandey, Veni Pande, Diksha Sati, Shobha Upreti & Mukesh Samant. (2020) Vaccination strategies to combat novel corona virus SARS-CoV-2. Life Sciences 256, pages 117956.
Crossref
Crossref
Jie Liu, Wanli Xie, Yanting Wang, Yue Xiong, Shiqiang Chen, Jingjing Han & Qingping Wu. (2020) A comparative overview of COVID-19, MERS and SARS: Review article. International Journal of Surgery 81, pages 1-8.
Crossref
Crossref
Gabriel Dagotto, Jingyou Yu & Dan H. Barouch. (2020) Approaches and Challenges in SARS-CoV-2 Vaccine Development. Cell Host & Microbe 28:3, pages 364-370.
Crossref
Crossref
Lauren A. Callender, Michelle Curran, Stephanie M. Bates, Maelle Mairesse, Julia Weigandt & Catherine J. Betts. (2020) The Impact of Pre-existing Comorbidities and Therapeutic Interventions on COVID-19. Frontiers in Immunology 11.
Crossref
Crossref
Jawad Al-Kassmy, Jannie Pedersen & Gary Kobinger. (2020) Vaccine Candidates against Coronavirus Infections. Where Does COVID-19 Stand?. Viruses 12:8, pages 861.
Crossref
Crossref
Vibhuti Kumar Shah, Priyanka Firmal, Aftab Alam, Dipyaman Ganguly & Samit Chattopadhyay. (2020) Overview of Immune Response During SARS-CoV-2 Infection: Lessons From the Past. Frontiers in Immunology 11.
Crossref
Crossref
Alberto Boretti. (2020) Sustainable Post Covid19 Lockdown Strategy Through Evidence-Based Policy. Integrative Journal of Medical Sciences 7.
Crossref
Crossref
Parismita Kalita, Aditya K. Padhi, Kam Y.J. Zhang & Timir Tripathi. (2020) Design of a peptide-based subunit vaccine against novel coronavirus SARS-CoV-2. Microbial Pathogenesis 145, pages 104236.
Crossref
Crossref
Amit Kumar Gupta, Md. Shoaib Khan, Shubham Choudhury, Adhip Mukhopadhyay, Sakshi, Amber Rastogi, Anamika Thakur, Pallawi Kumari, Manmeet Kaur, Shalu, Chanchal Saini, Vandna Sapehia, Barkha, Pradeep Kumar Patel, Kailash T. Bhamare & Manoj Kumar. (2020) CoronaVR: A Computational Resource and Analysis of Epitopes and Therapeutics for Severe Acute Respiratory Syndrome Coronavirus-2. Frontiers in Microbiology 11.
Crossref
Crossref
Edison Ong, Mei U Wong, Anthony Huffman & Yongqun He. (2020) COVID-19 Coronavirus Vaccine Design Using Reverse Vaccinology and Machine Learning. Frontiers in Immunology 11.
Crossref
Crossref
Christin Scheller, Finja Krebs, Robert Minkner, Isabel Astner, Maria Gil‐Moles & Hermann Wätzig. (2020) Physicochemical properties of SARS‐CoV‐2 for drug targeting, virus inactivation and attenuation, vaccine formulation and quality control. ELECTROPHORESIS 41:13-14, pages 1137-1151.
Crossref
Crossref
Alejandro Llanes, Carlos M. Restrepo, Zuleima Caballero, Sreekumari Rajeev, Melissa A. Kennedy & Ricardo Lleonart. (2020) Betacoronavirus Genomes: How Genomic Information has been Used to Deal with Past Outbreaks and the COVID-19 Pandemic. International Journal of Molecular Sciences 21:12, pages 4546.
Crossref
Crossref
Murat TOPUZOĞULLARI, Tayfun ACAR, Pelin PELİT ARAYICI, Burcu UÇAR, Erennur UĞUREL, Emrah Şefik ABAMOR, Tülin ARASOĞLU, Dilek TURGUT-BALIK & Serap DERMAN. (2020) An insight into the epitope-based peptide vaccine design strategy and studies against COVID-19. TURKISH JOURNAL OF BIOLOGY 44:3, pages 215-227.
Crossref
Crossref
Cristiano Conte, Francesco Sogni, Paola Affanni, Licia Veronesi, Alberto Argentiero & Susanna Esposito. (2020) Vaccines against Coronaviruses: The State of the Art. Vaccines 8:2, pages 309.
Crossref
Crossref
So-Hee Hong, Hyo-Jung Park & Jae-Hwan Nam. (2020) Lessons Learned from SARS-CoV and MERS-CoV: Preparation for SARS-CoV-2 induced COVID-19. Journal of Bacteriology and Virology 50:2, pages 76-96.
Crossref
Crossref
Sabari Nath Neerukonda & Upendra Katneni. (2020) A Review on SARS-CoV-2 Virology, Pathophysiology, Animal Models, and Anti-Viral Interventions. Pathogens 9:6, pages 426.
Crossref
Crossref
Ghazaleh Jamalipour Soufi, Ali Hekmatnia, Mahmoud Nasrollahzadeh, Nasrin Shafiei, Mohaddeseh Sajjadi, Parisa Iravani, Salman Fallah, Siavash Iravani & Rajender S. Varma. (2020) SARS-CoV-2 (COVID-19): New Discoveries and Current Challenges. Applied Sciences 10:10, pages 3641.
Crossref
Crossref
Gangqiang Guo, Lele Ye, Kan Pan, Yu Chen, Dong Xing, Kejing Yan, Zhiyuan Chen, Ning Ding, Wenshu Li, Hong Huang, Lifang Zhang, Xiaokun Li & Xiangyang Xue. (2020) New Insights of Emerging SARS-CoV-2: Epidemiology, Etiology, Clinical Features, Clinical Treatment, and Prevention. Frontiers in Cell and Developmental Biology 8.
Crossref
Crossref
Marcella Prete, Elvira Favoino, Giacomo Catacchio, Vito Racanelli & Federico Perosa. (2020) SARS-CoV-2 Inflammatory Syndrome. Clinical Features and Rationale for Immunological Treatment. International Journal of Molecular Sciences 21:9, pages 3377.
Crossref
Crossref
Dennis R. Burton & Laura M. Walker. (2020) Rational Vaccine Design in the Time of COVID-19. Cell Host & Microbe 27:5, pages 695-698.
Crossref
Crossref
Fatima Amanat & Florian Krammer. (2020) SARS-CoV-2 Vaccines: Status Report. Immunity 52:4, pages 583-589.
Crossref
Crossref
Linda J. Saif. (2020) VACCINES FOR COVID-19: PERSPECTIVES, PROSPECTS, AND CHALLENGES BASED ON CANDIDATE SARS, MERS, AND ANIMAL CORONAVIRUS VACCINES. European Medical Journal.
Crossref
Crossref
Weilong Shang, Yi Yang, Yifan Rao & Xiancai Rao. (2020) The outbreak of SARS-CoV-2 pneumonia calls for viral vaccines. npj Vaccines 5:1.
Crossref
Crossref
Jared S. Morse, Tyler Lalonde, Shiqing Xu & Wenshe Ray Liu. (2020) Learning from the Past: Possible Urgent Prevention and Treatment Options for Severe Acute Respiratory Infections Caused by 2019‐nCoV. ChemBioChem 21:5, pages 730-738.
Crossref
Crossref
Alberto Boretti. (2020) The Increasing Number of Infected in Victoria, Australia since June 15, 2020, is the Result of Over-Testing and Over-Controlling without Safety. Integrative Journal of Medical Sciences.
Crossref
Crossref
Zhiqi Song, Yanfeng Xu, Linlin Bao, Ling Zhang, Pin Yu, Yajin Qu, Hua Zhu, Wenjie Zhao, Yunlin Han & Chuan Qin. (2019) From SARS to MERS, Thrusting Coronaviruses into the Spotlight. Viruses 11:1, pages 59.
Crossref
Crossref
Susan M. Poutanen. 2018. Principles and Practice of Pediatric Infectious Diseases. Principles and Practice of Pediatric Infectious Diseases
1148
1152.e3
.
Katherine V. Houser, Andrew J. Broadbent, Lisa Gretebeck, Leatrice Vogel, Elaine W. Lamirande, Troy Sutton, Kevin W. Bock, Mahnaz Minai, Marlene Orandle, Ian N. Moore & Kanta Subbarao. (2017) Enhanced inflammation in New Zealand white rabbits when MERS-CoV reinfection occurs in the absence of neutralizing antibody. PLOS Pathogens 13:8, pages e1006565.
Crossref
Crossref
Júlia Vergara-Alert, Enric Vidal, Albert Bensaid & Joaquim Segalés. (2017) Searching for animal models and potential target species for emerging pathogens: Experience gained from Middle East respiratory syndrome (MERS) coronavirus. One Health 3, pages 34-40.
Crossref
Crossref
Sara I. Ruiz, Elizabeth E. Zumbrun & Aysegul Nalca. 2017. Animal Models for the Study of Human Disease. Animal Models for the Study of Human Disease
853
901
.
Emmie de Wit, Neeltje van Doremalen, Darryl Falzarano & Vincent J. Munster. (2016) SARS and MERS: recent insights into emerging coronaviruses. Nature Reviews Microbiology 14:8, pages 523-534.
Crossref
Crossref
Olivia C. Demurtas, Silvia Massa, Elena Illiano, Domenico De Martinis, Paul K. S. Chan, Paola Di Bonito & Rosella Franconi. (2016) Antigen Production in Plant to Tackle Infectious Diseases Flare Up: The Case of SARS. Frontiers in Plant Science 7.
Crossref
Crossref
Clifton McPherson, Richard Chubet, Kathy Holtz, Yoshikazu Honda-Okubo, Dale Barnard, Manon Cox & Nikolai Petrovsky. 2016. Vaccine Design. Vaccine Design
269
284
.
Tanya Burkholder, Carmen Ledesma Feliciano, Sue VandeWoude & Henry J. Baker. 2015. Laboratory Animal Medicine. Laboratory Animal Medicine
555
576
.
Naoko Iwata-Yoshikawa, Akihiko Uda, Tadaki Suzuki, Yasuko Tsunetsugu-Yokota, Yuko Sato, Shigeru Morikawa, Masato Tashiro, Tetsutaro Sata, Hideki Hasegawa & Noriyo Nagata. (2014) Effects of Toll-Like Receptor Stimulation on Eosinophilic Infiltration in Lungs of BALB/c Mice Immunized with UV-Inactivated Severe Acute Respiratory Syndrome-Related Coronavirus Vaccine. Journal of Virology 88:15, pages 8597-8614.
Crossref
Crossref
Nicolas Escriou, Benoît Callendret, Valérie Lorin, Chantal Combredet, Philippe Marianneau, Michèle Février & Frédéric Tangy. (2014) Protection from SARS coronavirus conferred by live measles vaccine expressing the spike glycoprotein. Virology 452-453, pages 32-41.
Crossref
Crossref
Rachel L. Graham, Eric F. Donaldson & Ralph S. Baric. (2013) A decade after SARS: strategies for controlling emerging coronaviruses. Nature Reviews Microbiology 11:12, pages 836-848.
Crossref
Crossref
Jie LiLaura UlitzkyErica SilbersteinDeborah R. TaylorRaphael Viscidi. (2013) Immunogenicity and Protection Efficacy of Monomeric and Trimeric Recombinant SARS Coronavirus Spike Protein Subunit Vaccine Candidates. Viral Immunology 26:2, pages 126-132.
Crossref
Crossref
Sara I. Ruiz, Elizabeth E. Zumbrun & Aysegul Nalca. 2013. Animal Models for the Study of Human Disease. Animal Models for the Study of Human Disease
927
970
.
Dharmendra Raghuwanshi, Vivek Mishra, Dipankar Das, Kamaljit Kaur & Mavanur R. Suresh. (2012) Dendritic Cell Targeted Chitosan Nanoparticles for Nasal DNA Immunization against SARS CoV Nucleocapsid Protein. Molecular Pharmaceutics 9:4, pages 946-956.
Crossref
Crossref
Naohiro Seo & Hiroshi Shiku. (2012) The possibility of antigenic peptide, protein and DNA delivery by percutaneous vaccination. Drug Delivery System 27:3, pages 194-201.
Crossref
Crossref
Susan M. Poutanen. 2012. Principles and Practice of Pediatric Infectious Diseases. Principles and Practice of Pediatric Infectious Diseases
1117
1120.e4
.
Yoshio Fujita & Hiroaki Taguchi. (2011) Current status of multiple antigen-presenting peptide vaccine systems: Application of organic and inorganic nanoparticles. Chemistry Central Journal 5:1.
Crossref
Crossref
Martial Jaume, Ming S. Yip, Chung Y. Cheung, Hiu L. Leung, Ping H. Li, Francois Kien, Isabelle Dutry, Benoît Callendret, Nicolas Escriou, Ralf AltmeyerBeatrice Nal, Marc Daëron, Roberto Bruzzone & J. S. Malik Peiris. (2011) Anti-Severe Acute Respiratory Syndrome Coronavirus Spike Antibodies Trigger Infection of Human Immune Cells via a pH- and Cysteine Protease-Independent FcγR Pathway. Journal of Virology 85:20, pages 10582-10597.
Crossref
Crossref
Ye V. Liu, Michael J. Massare, Dale L. Barnard, Thomas Kort, Margret Nathan, Lei Wang & Gale Smith. (2011) Chimeric severe acute respiratory syndrome coronavirus (SARS-CoV) S glycoprotein and influenza matrix 1 efficiently form virus-like particles (VLPs) that protect mice against challenge with SARS-CoV. Vaccine 29:38, pages 6606-6613.
Crossref
Crossref
Luis Enjuanes, Jose L. Nieto-Torres, Jose M. Jimenez-Guardeño & Marta L. DeDiego. 2011. Replicating Vaccines. Replicating Vaccines
73
97
.
Anjeanette RobertsElaine W. LamirandeLeatrice VogelBenoît BarasGeneviève GoossensIsabelle KnottJun ChenJerrold M. WardVentzislav VassilevKanta Subbarao. (2010) Immunogenicity and Protective Efficacy in Mice and Hamsters of a β-Propiolactone Inactivated Whole Virus SARS-CoV Vaccine. Viral Immunology 23:5, pages 509-519.
Crossref
Crossref